Disease | erythromelalgia |
Symptom | C0030193|pain |
Sentences | 3 |
PubMedID- 19481586 | Microneurographic findings of relevance to pain in patients with erythromelalgia and patients with diabetic neuropathy. |
PubMedID- 24278716 | Xenon pharmaceuticals reported that, in a pilot study, the nav1.7 blocker xen402 produced marked and significant pain reduction in patients with erythromelalgia . |
PubMedID- 23828645 | Moreover, a na+-channel blocker has been shown to be effective in relieving spontaneous pain in individuals with erythromelalgia (goldberg et al., 2012). |
Page: 1